Search hospitals > Georgia > Atlanta
Emory University Hospital Midtown
Claim this profileAtlanta, Georgia 30308
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Breast cancer
Conducts research for Cancer
Conducts research for Squamous Cell Carcinoma
366 reported clinical trials
69 medical researchers
Summary
Emory University Hospital Midtown is a medical facility located in Atlanta, Georgia. This center is recognized for care of Lung Cancer, Breast Cancer, Breast cancer, Cancer, Squamous Cell Carcinoma and other specialties. Emory University Hospital Midtown is involved with conducting 366 clinical trials across 571 conditions. There are 69 research doctors associated with this hospital, such as Conor Steuer, Ticiana A. Leal, Olatunji Alese, and Mehmet Bilen, MD.Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Conor SteuerEmory University Hospital Midtown1 year of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
17 reported clinical trials
38 drugs studied
Ticiana A. LealUniversity of Wisconsin Hospital and Clinics5 years of reported clinical research
Expert in Lung Cancer
Studies Non-Small Cell Lung Cancer
17 reported clinical trials
24 drugs studied
Olatunji AleseEmory University Hospital/Winship Cancer Institute7 years of reported clinical research
Studies Pancreatic Cancer
Studies Colorectal Cancer
17 reported clinical trials
42 drugs studied
Mehmet Bilen, MDEmory University Hospital/Winship Cancer Institute3 years of reported clinical research
Studies Prostate Cancer
Studies Kidney Cancer
16 reported clinical trials
47 drugs studied
Clinical Trials running at Emory University Hospital Midtown
Lung Cancer
Breast Cancer
Skin Cancer
Breast cancer
Prostate Cancer
Cancer
Ovarian Cancer
Liver Cancer
Uterine Cancer
Laryngeal Cancer
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Lurbinectedin + Radiotherapy
for Small Cell Lung Cancer
This phase I trial aims to determine if it is safe to use palliative radiotherapy and lurbinectedin at the same time to treat small cell lung cancer that has spread outside of the chest and that has grown after being treated with chemotherapy (extensive stage). Lurbinectedin kills tumor cells by blocks a process called transcription that small cell lung cancer relies on to survive. It also damages the deoxyribonucleic acid (DNA) of tumor cells, which is similar to the way radiation kills tumor cells. Palliative radiotherapy is a routine medical treatment for patients who have lung cancer that has spread to other parts of the body (metastatic), and is used to relieve symptoms caused by cancer or to patients from developing symptoms. This trial may help doctors understand if treating patients with lurbinectedin and palliative radiotherapy at the same time would make them both work better than either one alone or if they could cause more side effects for patients when given together.
Recruiting2 awards Phase 116 criteria
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting2 awards Phase 312 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Emory University Hospital Midtown?
Emory University Hospital Midtown is a medical facility located in Atlanta, Georgia. This center is recognized for care of Lung Cancer, Breast Cancer, Breast cancer, Cancer, Squamous Cell Carcinoma and other specialties. Emory University Hospital Midtown is involved with conducting 366 clinical trials across 571 conditions. There are 69 research doctors associated with this hospital, such as Conor Steuer, Ticiana A. Leal, Olatunji Alese, and Mehmet Bilen, MD.
Where is Emory University Hospital Midtown located?
To reach Emory University Hospital Midtown in Atlanta, Georgia from the South, take I-75/85 Northbound. Exit at Clairmont Road (exit #91), follow signs to Decatur, and continue on Clairmont Road for approximately 4-5 miles. Turn right onto North Decatur Road, proceed for one mile, then turn right onto Clifton Road; the hospital is located 100 yards on the left.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Emory University Hospital Midtown, contact the Patient Access Department at 404-686-8947 or 1-855-432-3080. Applications can be submitted at any time either by phone or in person as detailed in the policy. For Emory Healthcare Retail/Specialty Pharmacies financial assistance, send applications to Pharmacy, 1750 Gambrell Drive, Suite T203, Atlanta, GA 30322, or fax to 404-778-2025.
What insurance does Emory University Hospital Midtown accept?
Emory University Hospital Midtown accepts several insurance plans, including the Kaiser Permanente Plan and the POS Plan. The Kaiser Permanente Plan offers access to a wide range of services including primary and specialty care, lab and pharmacy services, and various care options like express, urgent, emergency, and inpatient hospital care. The POS Plan allows for copays and coinsurance, with a deductible, and features three network options: Tier 1, Tier 2, and Tier 3, each with different copays, coinsurance, and deductibles. Additionally, Emory Healthcare accepts most major insurance plans, such as private and employer-based plans, Federal health insurance marketplace plans, traditional Medicare, and Medicare Advantage plans.
What awards or recognition has Emory University Hospital Midtown received?
Emory University Hospital Midtown, located in Atlanta, Georgia, is celebrated for its excellence, being ranked as the number one hospital in both metro Atlanta and Georgia by U.S. News & World Report. It boasts rankings in 10 adult specialty areas and is recognized as high-performing in three additional specialties. The hospital's Public Safety Department has also been honored with a Program of Distinction award by the International Association for Healthcare Security and Safety.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.